Literature DB >> 11112699

Abnormal localisation and hyperclustering of (alpha)(V)(beta)(3) integrins and associated proteins in Src-deficient or tyrphostin A9-treated osteoclasts.

P T Lakkakorpi1, I Nakamura, M Young, L Lipfert, G A Rodan, L T Duong.   

Abstract

The non-receptor tyrosine kinase Src was shown to be essential for osteoclast function in vivo. We have previously reported that engagement of (alpha)(v)(beta)(3) integrin in osteoclasts induces tyrosine phosphorylation and activation of the adhesion kinase PYK2 and the adaptor protein p130(Cas) in a Src-dependent manner. The objective of this study was to analyse the role of c-Src in the (alpha)(v)(beta)(3) integrin-dependent recruitment of signalling and cytoskeletal molecules in osteoclasts during bone resorption. Using prefusion osteoclasts (pOCs) obtained from cocultures of osteoblasts and spleen cells isolated from Src(-/-) mice or their normal littermates, we found: (1) similar expression levels and ligand binding affinities of (alpha)(v)(beta)(3) integrins in Src(-/-) and Src(+/?) pOCs, (2) reduced adhesion and spreading of Src(-/-) pOCs, (3) defective organisation of the microfilament proteins, F-actin, vinculin and paxillin, and of PYK2 and p130(Cas) in the sealing zone of Src(-/-)OCLs, and (4) hyperclustering of (alpha)(v)(beta)(3) integrins together with microfilament and signalling proteins in the basal membrane of Src-deficient OCLs. In normal OCLs, the tyrosine kinase inhibitor tyrphostin A9 inhibits actin ring formation, bone resorption and tyrosine phosphorylation of several proteins, including c-Src. Furthermore, tyrphostin A9 induced similar hyperclustering of (alpha)(v)(beta)(3) integrins in osteoclasts as observed in Src(-/-) OCLs. Taken together, these findings suggest that normal localisation of (alpha)(v)(beta)(3) and recruitment of its downstream effectors to the appropriate compartments of the osteoclast during resorption depend on Src kinase activity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11112699     DOI: 10.1242/jcs.114.1.149

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  19 in total

1.  Src kinase activation by direct interaction with the integrin beta cytoplasmic domain.

Authors:  Elena G Arias-Salgado; Sergio Lizano; Sugata Sarkar; Joan S Brugge; Mark H Ginsberg; Sanford J Shattil
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-30       Impact factor: 11.205

2.  Regulation of sealing ring formation by L-plastin and cortactin in osteoclasts.

Authors:  Tao Ma; Kavitha Sadashivaiah; Nandakumar Madayiputhiya; Meenakshi A Chellaiah
Journal:  J Biol Chem       Date:  2010-07-22       Impact factor: 5.157

3.  L-Plastin deficiency produces increased trabecular bone due to attenuation of sealing ring formation and osteoclast dysfunction.

Authors:  Meenakshi A Chellaiah; Megan C Moorer; Sunipa Majumdar; Hanan Aljohani; Sharon C Morley; Vanessa Yingling; Joseph P Stains
Journal:  Bone Res       Date:  2020-01-22       Impact factor: 13.567

Review 4.  A novel miR17/protein tyrosine phosphatase-oc/EphA4 regulatory axis of osteoclast activity.

Authors:  Kin-Hing William Lau; Matilda H-C Sheng
Journal:  Arch Biochem Biophys       Date:  2018-05-17       Impact factor: 4.013

5.  Cell surface transglutaminase promotes RhoA activation via integrin clustering and suppression of the Src-p190RhoGAP signaling pathway.

Authors:  Anna Janiak; Evgeny A Zemskov; Alexey M Belkin
Journal:  Mol Biol Cell       Date:  2006-02-01       Impact factor: 4.138

6.  Analysis of the signaling pathways regulating Src-dependent remodeling of the actin cytoskeleton.

Authors:  Sabina E Winograd-Katz; Michal C Brunner; Natalia Mirlas; Benjamin Geiger
Journal:  Eur J Cell Biol       Date:  2010-08-17       Impact factor: 4.492

7.  Pyk2 mediates increased adrenergic contractile responses in arteries from DOCA-salt mice - VASOACTIVE PEPTIDE SYMPOSIUM.

Authors:  Fernanda R C Giachini; Fernando S Carneiro; Victor V Lima; Zidonia N Carneiro; Maria Helena C Carvalho; Zuleica B Fortes; R Clinton Webb; Rita C Tostes
Journal:  J Am Soc Hypertens       Date:  2008 Nov-Dec

8.  Dynamin reduces Pyk2 Y402 phosphorylation and SRC binding in osteoclasts.

Authors:  Angela Bruzzaniti; Lynn Neff; Amanda Sandoval; Liping Du; William C Horne; Roland Baron
Journal:  Mol Cell Biol       Date:  2009-04-20       Impact factor: 4.272

9.  The tyrosine kinase activity of c-Src regulates actin dynamics and organization of podosomes in osteoclasts.

Authors:  Olivier Destaing; Archana Sanjay; Cecile Itzstein; William C Horne; Derek Toomre; Pietro De Camilli; Roland Baron
Journal:  Mol Biol Cell       Date:  2007-10-31       Impact factor: 4.138

10.  Disruption of c-Jun reduces cellular migration and invasion through inhibition of c-Src and hyperactivation of ROCK II kinase.

Authors:  Xuanmao Jiao; Sanjay Katiyar; Manran Liu; Susette C Mueller; Michael P Lisanti; Anping Li; Timothy G Pestell; Kongming Wu; Xiaoming Ju; Zhiping Li; Erwin F Wagner; Tatsuo Takeya; Chenguang Wang; Richard G Pestell
Journal:  Mol Biol Cell       Date:  2008-01-23       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.